ConductScience.org, home

Paper39467628

Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma.

Doelker T and 2 others. Cancer Genomics Proteomics, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma. Papers, record 39467628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39467628

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma.
PubMed
Journal
Cancer Genomics Proteomics
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.21, provisional
iCite
Revised in PubMed
2024-11-06
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Doelker TTammy
2Gallwas JJulia
3Gründker CCarsten

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, G-Protein-CoupledMajor topic
Receptors, EstrogenMajor topic
Plasminogen Activator Inhibitor 1Major topic
Vulvar NeoplasmsMajor topic
Cell ProliferationMajor topic
Disease ProgressionMajor topic
Cell MovementMajor topic
Humans
Female
Cell Line, Tumor
Gene Expression Regulation, Neoplastic

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126527320Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs.Oncotarget2016https://conductscience.org/library/papers/26527320PubMed
235119068The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.Clin Sci (Lond)2022https://conductscience.org/library/papers/35119068PubMed
39701244Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.Nat Med1998https://conductscience.org/library/papers/9701244PubMed
437762008Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells.Int J Mol Sci2023https://conductscience.org/library/papers/37762008PubMed
531611744Estrogen receptor subtype agonist activation in human cutaneous squamous cell carcinoma cells modulates expression of CD55 and Cyclin D1.EXCLI J2019https://conductscience.org/library/papers/31611744PubMed
625386620Functional stability of plasminogen activator inhibitor-1.ScientificWorldJournal2014https://conductscience.org/library/papers/25386620PubMed
728258163G-1 Inhibits Breast Cancer Cell Growth via Targeting Colchicine-Binding Site of Tubulin to Interfere with Microtubule Assembly.Mol Cancer Ther2017https://conductscience.org/library/papers/28258163PubMed
829887999Adipose Tissue-Secreted Factors Alter Bladder Cancer Cell Migration.J Obes2018https://conductscience.org/library/papers/29887999PubMed
933117280Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/33117280PubMed
1023988000Serpins for diagnosis and therapy in cancer.Cardiovasc Hematol Disord Drug Targets2013https://conductscience.org/library/papers/23988000PubMed
1115149846Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.Exp Cell Res2004https://conductscience.org/library/papers/15149846PubMed
1238821619MRI Texture Analysis of Inguinal Lymph Node Metastasis in Vulvar Cancer - Associations With Histopathology.Anticancer Res2024https://conductscience.org/library/papers/38821619PubMed
1328758928Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.Int J Mol Sci2017https://conductscience.org/library/papers/28758928PubMed
1437345182Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/37345182PubMed
1530687231Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER.Front Endocrinol (Lausanne)2018https://conductscience.org/library/papers/30687231PubMed
1637415190Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/37415190PubMed
1733415130Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.Front Cardiovasc Med2020https://conductscience.org/library/papers/33415130PubMed
1833367928Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells.Int J Oncol2021https://conductscience.org/library/papers/33367928PubMed
1931072060GPCR-Hippo Signaling in Cancer.Cells2019https://conductscience.org/library/papers/31072060PubMed
2033538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed

See all 39 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42379802Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro.In Vivo2026https://conductscience.org/library/papers/42379802PubMed
42232322INHIBITING THE INHIBITOR: WOULD TARGETING PAI-1 RESULT IN A LOW-DOSE, WELL-TOLERATED TREATMENT OF EMPYEMA?Biomed Sci Instrum2025https://conductscience.org/library/papers/42232322PubMed
40280717Expression of "Hallmarks of Cancer" Genes in Cervical Carcinoma Is Differentially Affected by GPER1 Overexpression Depending on Histologic Entity.Cancer Genomics Proteomics2025https://conductscience.org/library/papers/40280717PubMed
40002669Constructing a Glioblastoma Prognostic Model Related to Fatty Acid Metabolism Using Machine Learning and Identifying F13A1 as a Potential Target.Biomedicines2025https://conductscience.org/library/papers/40002669PubMed
39738932
Identification of a gene score related to antigen processing and presentation machinery for predicting prognosis in head and neck squamous cell carcinoma and its potential implications for immunotherapy.
Clin Transl Oncol2025https://conductscience.org/library/papers/39738932PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GPER12852PubTator's text mininghttps://conductscience.org/library/genes/2852NCBI Gene
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39467628

GET https://conductscience.org/api/papers/v1/39467628/references?page=2